Richards: "UK cancer patients should ‘bother’ the GP!"
This article was originally published in Clinica
If the UK’s five-year cancer survival rates were raised to those of the best-performing European countries, some 11,000 lives could be saved every year. So said UK national cancer director Mike Richards today, at the unveiling of the UK’s National Awareness and Early Diagnosis Initiative (NAEDI). It is hoped that the initiative, which is part of the national Cancer Reform Strategy, will address this imbalance, said Prof Richards, who is also a director of the charity, Cancer Research UK (CRUK).
You may also be interested in...
ABHI director of value and access Luella Trickett talks about the importance of real-world evidence in product development and value-based procurement in secondary care in the UK.
UK health minister Baroness Blackwood will introduce the new UK Medicines and Medical Devices Bill before Parliament today, just before the House of Commons goes into recess. The government wants new legislation for devices and medicines in place before the end of the Brexit transition period.
EU medical device consultant Trevor Lewis takes note of the recent, if belated, progress towards the building of the post-MDR playing field for medical device companies in Europe, but calls political decision-makers and economic operators to account: getting it right is nothing short of a matter of life and death, he tells In Vivo.